Antigen-presenting cells contain a specialized late endocytic compartment, MIIC (major histocompatibility complex [MHC] class II-enriched compartment), that harbors newly synthesized MHC class II molecules in transit to the plasma membrane. MIICs have a limiting membrane enclosing characteristic internal membrane vesicles. Both the limiting membrane and the internal vesicles contain MHC class II. In this study on B lymphoblastoid cells, we demonstrate by immunoelectron miroscopy that the limiting membrane of MIICs can fuse directly with the plasma membrane, resulting in release from the cells of internal MHC class II-containing vesicles. These secreted vesicles, named exosomes, were isolated from the cell culture media by differential centrifugation followed by flotation on sucrose density gradients. The overall surface protein composition of exosomes differed significantly from that of the plasma membrane. Exosome-bound MHC class II was in a compact, peptide-bound conformation. Metabolically labeled MHC class II was released into the extracellular medium with relatively slow kinetics, 10 -4% in 24 h, indicating that direct fusion of MIICs with the plasma membrane is not the major pathway by which MHC class II reaches the plasma membrane. Exosomes derived from both human and murine B lymphocytes induced antigen-specific MHC class II-restricted T cell responses. These data suggest a role for exosomes in antigen presentation in vivo.
H
elper T lymphocytes recognize exogenous antigens bound to MHC class II molecules, displayed at the surface of a variety of APC such as macrophages, B lymphocytes, and dendritic cells including Langerhans cells of the epidermis. MHC class II molecules are heterodimers of two transmembrane proteins, an ot and 13 subunit with molecular masses of 33-35 and 25-30 kD, respectively. After biosynthesis, ot and 13 subunits assemble in the endoplasmic reticulum with trimers of a nonpolymorphic type II transmembrane polypeptide, the invariant (I) chain (1, 2) . After transport to the Golgi complex, most of the class II molecules are targeted to endocytic compartments (3, 4) , where the I chains are dissociated from the cx/[3 dimers, and degraded, leaving MHC class II molecules ready to bind peptides derived from endocytosed proteins (5-7). Recent evidence has shown that I chain dissociation and peptide binding are facilitated by HLA-DM molecules (8) .
We have recently demonstrated that in human B cells (9) and in dendritic cells, including Langerhans cells (10) (11) (12) and macrophages (13) , most of the intracellular class II molecules reside in MHC class II-enriched compartments (MIICs). 1 MIICs have lysosomal characteristics: they contain lysosomal marker molecules (LAMP1, CD63, [3-hexosaminidase, and cathepsin D), are positioned late in the endocytic pathway, and are acidic (14) . A further characterization of MIICs was accomplished with their purification from murine macrophages (15) , human B cells (16) , murine B cells (17, 18) , and melanoma cells (19) . Interestingly, it has recently been shown by immunoelectron microscopy that the majority of HLA-DM molecules also resides in MIICs (20) . Together, these studies indicate that MIICs are involved in antigen processing and peptide binding to class II molecules. However, functionally different subclasses of MIICs may exist (16, 18) . In all APC studied so far, MIICs and related compartments contain internal membranes (9, 14, 16) . These membranes probably originate from inward vesiculation of the limiting membrane of MIICs (21) . Two types of MIICs could be distinguished by morphological criteria: those displaying numer~Abbreviations used in this paper: BSAG, gold particles derivitized with BSA; MIIC, MHC class II-enriched compartment; TilL, transferrin receptor.
ous internal vesicles and those containing membrane sheets (10, 16, 22) . Whether these two types of MIICs have differential functions in antigen processing and presentation remains to be established.
A major unresolved question in MHC class II trafficking concerns the pathway via which intracellular class II molecules are transferred to the cell surface. In macrophages, vesicles emanating from class II-enriched phagolysosomes have been suggested to provide for transport of MHC class II molecules to the plasma membrane (13) . However, so far such vesicles have not been identified in other APC. MIICs in B cells and Langerhans cells are spherical structures without attached vesicles and tubules (9) (10) (11) (12) . Alternatively, MHC class II molecules may be transported to the plasma membrane by trans-Golgl network-derived vesicles (1, 23) .
So far no evidence has been presented for either of these pathways.
Using immunoelectron microscopy, biochemistry, and antigen presentation assays, we now show that in B cells MIICs are exocytic compartments. After fusion with the plasma membrane, small vesicles contained within the lumen of the MIICs are released into the extracellular milieu. The externalized vesicles, termed exosomes analogous to vesicles released by reticulocytes (24) (25) (26) , exhibited abundant MHC class II molecules at their surface, and specifically presented antigenic peptides to T cells. Possible roles ofexosomes in vivo are discussed.
Materials and Methods
Cell Lines and Antibodies. The EBV-transformed human B cell lines RN (HLA-DR15 +) and JY (HLA-DR15-) were cultured in RPMI medium (Gibco Laboratories, Paisley, Scotland) supplemented with 10% FCS (Hyclone Laboratories, Inc., Logan, UT) and 100 IU penicillin. The T cell clone 2F10 recognizing the peptide 418-427 from the HSP65 antigen of Mycobacterium leprae in the context of HLA-DR15 was generated as described (27, 28) and cultured in IMDM (Gibco Laboratories) supplemented with 10% heat-inactivated pooled human serum. The murine B cell line TA3 (H-2 k,d) (29) 
Isolation and Puri~qcation qf Exosomes. RN cells were washed
by centrifugation and recultured in fresh medium for 2 d. Cell culture media (35 nil) containing 2-5 X 10 v cells were centrifuged for 10 mm at 300g to remove the cells. After a second centrifugation at 300 g, the medium was centrifuged for 10 rain at 1,200 g (2 • 30 nfin at 10,000 g, 60 rain at 70,000 g, and 60 min at 100,000 g sequentially, using a rotor (SW27; Beckman Instruments, Inc., Fullerton, CA). The pellets were solubilized in nonreducing SDS sample buffer at room temperature for analysis by SDS-PAGE and Western blotting as described previously using 12SI-protein A (35) . When indicated, aliquots of the samples were incubated at 100~ in the presence of [$-ME. For electron nilcroscopy, the 70,000-g pellet was resuspended in 100 pA of RPMI medium. For further purification of exosomes, the 70,000-g pellet was resuspended in 5 nil of 2.5 M sucrose, 20 mM Hepes/NaOH, pH 7.2. A linear sucrose gradient (2-0.25 M sucrose, 20 mM Hepes/NaOH, pH 7.2) was layered on top of the exosome suspension in a tube (SW27; Beckman Instruments, Inc.), and the sample was centrifugated at 100,000 g for 15 h. Gradient fractions (18 • 2 ml) were collected from the bottom of the tube, diluted with 3 ml PBS, and ultracentrifuged for 1 h at 200,000 g using a rotor (SW50; Beckman Instruments, Inc. The mAbs were adsorbed from hybridoma culture supernatants using protein A-Sepharose beads (Pharmacia Biotech Inc., Piscataway, NJ). Antibody-coated beads were washed with inununomix (50 mM Tris-HC1, pH 7.5, 0.5% NP-40, 5 mM EDTA, 150 mM NaC1, 0.1 mM PMSF) and added to the lysates that had been precleared with protein A-Sepharose. After a 16-h incubation at 4~ the beads were washed extensively with immunomix, lmmunoprecipitated MHC class II and samples of the total cell and exosome lysates were eluted from the beads in SDS sample buffer at reducing conditions at 95~ and analyzed by SDS-PAGE and Western blotting. After the transfer to Immobilon-P membranes (Millipore Corp., Milford, MA), the membranes were blocked in PBS containing 0.1% gelatin, 0.05 Triton X-100, and 0.01% antifoam (Sigma Chemical Co., St. Louis, MO). Biotinylated proteins were labeled using USl-streptavidin (0.1 p~g/nil, 2 • l0 ~ cpm/p~g) and detected using a Phospholmager (Molecular Dynamics).
Afetabolic Labeling. Cells were washed three times with MEM lacking methionine and cysteine and preincubated for 45 rain at 37~ in a 5% CO, atmosphere. Cells were then pulsed for 45 rain with 50 Mbq/ml [3SS]methionine (Tran-S-label; ICN, Irvine, CA) and chased for different periods of time in RPMI supplemented with 10% FCS, 1 mM methionine, and 1 mM cysteine (5 • 10 v cells/time point). Afi:er pulse-chase labeling, the cells were pelleted by centrifugation ~br 10 min at 300g. The supernatants were collected and centrifuged for 5 rain at 10,000 g followed by 30 rain at 200,000 g in a rotor (model SW60; Beckman Instruments, Inc.). Cells and the 200,000-g pellets were lysed in lysis buffer as described above. Nuclei were removed from the cell lysates by centrifugation for 5 min at 10,000 g. MHC class II was immunoprecipitated as described above. Till was immunoprecipitated as described previously (35) . Precipitated MHC class II was eluted from the beads in SDS sample buffer at nonreducing conditions at room temperature. Precipitated Tfl~ was eluted from the beads in SDS-sample buffer at reducing conditions at 95~ Immunoprecipitates were analyzed by SDS-PAGE and fluorography. MHC class II was quantified using a Phospholmager.
hnmunoelectron Microscopy. The ILN B cell line and the T2-DR.3
cell line were pulse incubated with 5-nm gold particles derivitized with BSA (BSAG ODs20 = 5 in RPMI medium lacking serum) for 10 rain at 37~ The cells were washed extensively at 4~ with RPMI medium by centrifugation and chase incubated at 37~ for 10, 20, 50 or 80 rain in the absence of BSAG. The cells were fixed in a mixture of 2% paraformaldehyde-0.2% glutaraldehyde in 0.1 M phosphate buffer, pH 7.4, and processed for ultracryomicrotomy and immunolabeling (36) . To improve ultrastructure and visualization of membranes, the ultrathin cryosections were collected as described by Liou and Slot (37) . For electron microscopy of the isolated exosomes, droplets of RPMI with suspended membranes from 70,000-g pellets (see above) were put on Formvar-carbon-coated electron microscopy grids, fixed as above, immunolabeled, and stained using the method described for ultrathin cryosecrions. 
Antigen Presentation

Results
MIICs Can Fuse with the Plasma Membrane. MIICs con-
taining abundant MHC class II molecules are a general fea-ture of human and murine B lymphoblastoid cell lines (3, 9, 16, 22) . In this study we analyzed immunogold-labeled ultrathin cryosections of the human B cell line RN by immunoelectron microscopy and found typical MIICs with internal membranes abundantly labeled for MHC class II (Fig. 1) . Both multivesicular and multilaminar MIICs were present. The RN cells displayed many exocytic profiles suggesting fusion of the limiting membrane of MIICs with the plasma membrane. These profiles contained vesicles reminiscent of those present in the multivesicular MIICs (Fig.  2) . Membrane sheets were not found in the fusion profiles, indicating that predominandy multivesicular MIICs fused with the plasma membrane. We named the externahzed MIIC-derived vesicles exosomes analogous to vesicles that are released by reticulocytes as a consequence of fusion of multivesicular bodies with the plasma membrane (25, 26) . Both exosomes and the limiting membranes of the exocytic profiles were immunolabeled for MHC class II (Fig. 2) and for the lysosomal membrane proteins LAMP1 (Fig. 2 B) and CD63 (not shown).
To further demonstrate that the contents of MIICs can be exocytosed, we tested whether previously endocytosed BSAG particles were reextemalized and could be found in exocytic profiles. R.N cells were allowed to internalize BSAG particles for 10 rain at 37~ washed extensively at 4~ to remove extracellular BSAG, and chased in the absence of BSAG for varying periods of time at 37~ BSAG was detected in MIICs after 20 rain of chase ( Fig. 1) , consistent with previous observations on dendritic cells (10) (11) (12) , theJY B cell line (9) , and other B cells (16, 22) . MIICs containing internal vesicles (early MIICs) were reached by the BSAG before those accommodating membrane sheets (late MIICs) (Fig. 1) . BSAG began to appear in exocytic profiles after 20 rain of chase (Fig. 2 A) and was abundant after a 50-rain chase (Fig. 2 B) . The observation that BSAG was not associated with the plasma membrane after 10 min of chase indicated that BSAG recovered in exocytic profiles after prolonged chase times indeed resulted from reexternalization.
Isolation of Exosomes.
Exosomes were isolated from the culture media of RN cells by differential centrifugation (25) . Pelleted membranes were analyzed by Western blotting. The majority of MHC class II-containing membranes sedimented at 70,000 g (Fig. 3 A, lane 6) . To test whether secreted MHC class II molecules were membrane bound, membranes from the 70,000-g pellets were floated into linear sucrose gradients. Western blot anlaysis of nonboiled and nonreduced gradient fractions showed that compact, peptide-bound MHC class II molecules floated to an equilibrium density of I. 13 g/ml, confirming their association with membrane vesicles (Fig. 3 B) . Next, membranes from the 70,000-g pellet were analyzed morphologically. As can be seen in Fig. 3 C, the 70,000-g pellet was composed of a homogeneous population of vesicles of 60--80 nm that labeled for MHC class II. The vesicles were morphologically similar to those found in sections of MIICs ( Fig. 1 ) and exocytic profiles (Fig. 2) . We conclude that the secreted To investigate the possibility that the M H C class II-containing vesicles that sedimented at 70,000 g represent shed plasma membrane fragments, the presence of the T f K was monitored by Western blotting. Tfl~s are absent from MIICs (9) and from class II-enriched cell fractions in B cells (16) . In most cell types, including B cells, Tfl~s are predominantly present at the plasma membrane and in early endosomes. Tfl~s have been localized in the limiting membrane of multivesicular bodies in most cell types, but not in their internal vesicles (40) . Fig. 4 A shows that Tfl~s were only detectable in the cell lysate (lane 3) but not in the 70,000-g pellet (lane 4). The significant enrichment of M H C class II over TftL in the 70,000-g pellet compared with the cell lysate (compare lanes 1 and 2 with lanes 3 and 4, respectively) suggests that little if any shed plasma membrane contaminated the exosome preparation. To further analyze differences in protein composition of the plasma membrane and exosomes, plasma membrane proteins and exosomal membrane proteins were biotinylated. Probing Western blots with 125I-streptavidin revealed at least four proteins that are highly enriched in plasma membranes and four proteins that are highly enriched in exosomes (Fig. 4  B) . M H C class II was identified among the enriched biotinylated proteins in plasma membrane (lanes 3-5) and in exosomes (lanes 6-8) by immunoprecipitation. The differential membrane protein composition of the plasma membrane and exosomes again strongly indicates that exosomes did not derive from shed plasma membrane.
Release of Newly Synthesized Class II Molecules. To determine the kinetics and the extent to which newly synthesized M H C class II molecules are released into the medium, R N cells were metabolically pulse labeled with [3SS]methionine for 45 min and chased for different periods of time as indicated in Fig. 5 . Cells and exosomes were collected by centrifugation, lysed, and M H C class II was immunoprecipitated. After pulse labeling, the majority of 3SS-MHC class II in the cells was immunoprecipitated as SDS-unstable c~/[3-I chain complexes (Fig. 5 A) . These complexes were converted to SDS-stable, a/[3-peptide complexes N3 h after synthesis (not shown), consistent with the kinetics reported for other human B cell lines (3, 41) . After 6 h of chase, 3SS-MHC class II appeared in the compact configuration. Only very little 3SS-MHC class II was detected in the exosome fraction at this time. Increasing amounts of35S-compact M H C class II were recovered from the exosomes after 12 and 24 h of chase. After 24 h of chase, 10 + 4% (n = 5 from three independent experiments) of the total newly synthesized M H C class II was recovered from exosomes. As a control, newly synthesized 3SS-Tt~ was immunoprecipitated and analyzed by SDS-PAGE (Fig. 5 B) . After pulse labeling, the precursor form o f the Tfl~ was detected. Complex glycosylated 3SS-Tfl~, migrating at a slightly lower mobility, was detected after chasing the cells. In contrast to 3SS-MHC class II, no 3SS-Tt~ was found in the exosome fraction, even after 24 h o f chase, again illustrating the selective incorporation of M H C class II in exosomes. (28, 29) . In a parallel experiment, R N cells were allowed to endocytose the intact HSP 65 protein continuously for 24 h, washed, and incubated in the absence of antigen for another 24 h. Cells and exosornes isolated from the chase medium were then used to stimulate 2F10 cells as above. Both cells and exosomes incubated with antigenic peptide (Fig. 6 , A and C) and cells and exosomes derived from media of cells that were preincubated with antigen (Fig. 6 , B and D) were able to induce specific T cell responses. As a control, exosomes were prepared from culture media of an equivalent number o f DP, A5-negative JY cells that had been incubated either in the presence or absence of the antigen. Although JY cells secreted an equivalent amount of exosomes, these were ineffective in stimulating 2F10 T cell proliferation (not shown). For exosomes derived from (Fig. 6 D) . F o r P-,N cells that h a d b e e n p r e i n c u b a t e d w i t h a n t i g e n , 2 • 104 cells w e r e r e q u i r e d to a c h i e v e t h e h a l f -m a x i m a l T cell r es p o n s e (Fig. 6 B) . 4 and 7) . In the control lanes (5 and 8) , an irrelevant mAb was used. The precipitated samples were eluted at 95~ resuiting in the dissociation of the c~ and 13 chains (arrows). Biotinylated proteins were detected on Western blots using 125I-streptavidin. For the detection of total biotinylated proteins (lanes 1 and 2), the setting of the Phospholmager was six times less sensitive compared with the setting for the immunoprecipitates. Molecular mass markers (106, 80, 49.5, and 32.5 kD) are indicated at the fight. 
Exosomes Can
R N cells that h a d b e e n p r e i n c u b a t e d w i t h a n t i g e n , a halfm a x i m a l T cell r e s p o n s e was o b t a i n e d w i t h an a m o u n t o f e x o s o m e s s e c r e t e d b y 3 X 10 s cells in 24 h
T o test w h e t h e r t h e s e r e s p o n s e s w e r e ass o c i a t e d w i t h M H C class II, e x o s o m e s to w h i c h p e p t i d e h a d b e e n a d d e d w e r e i n c u b a t e d in t h
Discussion
In this study we show that, in B ceils, the bruiting m e mbrane o f MIICs can fuse with the plasma membrane in an exocytic fashion, resulting in the release of small membrane vesicles (exosomes) into the culture media. Exosome release as a consequence o f fusion ofmultivesicular bodies with the plasma membrane has been documented for reticulocytes (25, 26) . Although our observations suggest that this phenomenon is c o m m o n to several B ceil lines, it has not been described previously. Biochemical data of more than a decade ago on so-called shedding of class II molecules by murine B cell lines, however, may be related to the observations we describe here. These studies document the release of intact M H C class II molecules (43) recovered in 100,000-g fractions from B ceil culture media (44) . The M H C class II molecules were part of supramolecular particles containing membrane hpids (45) . The release was interpreted as shedding of plasma membrane. Our present observations throw new light on these data and suggest that the released M H C class II-containing particles in fact were exosomes. Other early studies demonstrated the presence of class II molecules associated with membrane hpids in serum (46) , which suggests the existence of exosomes in vivo. However, a possible relationship between exosomes and circulating forms o f M H C class II needs further analysis.
Our conclusion that MiICs in B cells are exocytic compartments is based on the following observations" (a) The plasma membrane showed indentations reminiscent of fused MIICs that contained vesicles similar in size and morphology to those present in intracellular MIICs (Fig. 2) . (b) The vesicles present in MIICs and at the ceil surface expressed the same markers, M H C class II (Fig. 2) , LAMP1 (Fig. 2 B) , and CD63 (not shown). LAMP1 and CD63 were not detected at other regions of the plasma membrane. (c) Internalized tracer particles were reexternalized and appeared in the M I I C fusion profiles (Fig. 2) . (d) Membrane vesicles similar in morphology to exosomes could be isolated from the culture media by differential centrifugation and flotation on sucrose gradients (Fig. 3 C) . (e) Purified exosomes did not contain TilLs, a marker for the plasma membrane and endosomes (Figs. 4 A and 5 B) . Furthermore, the total surface protein composition o f exosomes differed from that of the plasma membrane as revealed by surface biotinylation (Fig. 4 /3) . Together, these observations strongly argue against the idea that M H C class II-containing membranes in the media resulted from plasma membrane shedding. The release of M H C class II molecules from the ceils via exosomes is significant. W h e n the cells were metabolically labeled with [35S]methionine, within 24 h 10 • 4% of the newly synthesized M H C class I! was found in exosomes recovered from the media.
Cell fractionation studies from several laboratories have indicated that antigen processing and peptide loading of M H C class II molecules probably occurs in MIICs or re- lated endocytic compartments (15) (16) (17) (18) (19) . The pathway(s) via which intracellular MHC class II molecules are transported from the MIICs to the cell surface are presently unknown. Since the limiting membrane of MIICs contains MHC class II molecules and is incorporated in the plasma membrane during exocytic fusion, this pathway may contribute to MHC class II transport to the plasma membrane. However fusion of MIICs with the plasma membrane is not likely to be the only, or even the major, pathway of MHC class II delivery to the cell surface. First, our metabolic labeling data show that the release of newly synthesized MHC class II into the medium (Fig. 5 A) occurred with kinetics much slower than transport of newly synthesized MHC class II molecules from MIIC to the plasma membrane (3, 41) . A possible caveat of this interpretation is that sticking of released exosomes to the plasma membrane may slow down their recovery from the medium. Second, we found that predominantly multivesicular MIICs fused with the plasma membrane, whereas electron microscopic and cell fractionation data (16) suggest that significant amounts of MHC class II are transported to other types of MIICs. We have identified two types ofMIICs: multivescular ones that received endocy-tosed tracer first (early MIICs) and multilaminar MIICs positioned later in the endocytic pathway (late MIICs). The exocytic profiles, and the 70,000-g pellets obtained from the culture media, contained vesicles (exosomes) rather than membrane sheets, suggesting that secretion is mainly restricted to the multivesicular MIICs. The internal MIIC vesicles are formed by inward budding of the limiting membrane of MIICs (see reference 21, Figs. 16 and 17) similar to those described for multivesicular bodies in other cell types (47) . Therefore the exosomes were expected to expose the luminal domain of MHC class II molecules at their surface. This orientation was confirmed by immunogold labehng on cryosections of exosomes and by immunogold labeling of isolated intact exosomes. In multivesicular endosomes, which share many features with MIICs, internal vesicles contain receptors destined for degradation, whereas recycling receptors are sorted to the limiting membrane (40, 48) . MIICs in APC may represent a similar type of sorting device to spatially segregate MHC class II molecules to the intemal vesicles, in order to discharge them from the cells through exocytosis. Thus, fusion of MIICs with the plasma membrane may allow cells to discard MHC molecules via exosomes. However, we now document the presence of presentable peptide-MHC class II complexes at the surface of exosomes. Peptide generated and bound to MHC class II intracellularly, as well as those bound to MHC class II on exosomes in vitro, produced a strong, peptide-specific and MHC class II-restricted stimulation of T cells. Exosomes therefore fulfill the requirements to induce T cell responses, including the expression of ubiquitous accessory molecules (49) . Preliminary observations have indeed indicated that several of these molecules (]37, ICAM, LFA-3) are present in exosome preparations (our unpublished data). Our study does not provide conclusive information about the efficiency of antigen presentation by exosomes. From the data presented in Fig. 6 , it can be estimated that exosomes are ~10-20 times less efficient in antigen presentation than cells. However, it should be considered that in antigen presentation assays, contact between B and T cells may be optimized selectively because of sedimentation of cells but not of exosomes. Secretion of exosomes by B lymphocytes is reminiscent of that of the internal vesicles in cytolytic granules of CTL (50, 51) . Both MIICs and cytolytic granules are lysosomelike compartments. The internal vesicles of cytolytic granules are exocytosed by the CTL upon CTL-target cell interaction, and presumably mediate the killing of target cells (50) . Whether B cell exosomes also have an extracellular physiological role in vivo remains to be established. It has been suggested that follicular dendritic cells are able to pick up MHC class II molecules released by surrounding B cells by an unknown mechanism (52) . The possibility that exosomes provide for transfer units of MHC class II-peptide complexes between different cells of the immune system is worth studying. Preliminary observations on physiological APC like dendritic cells, monocytes, and macrophages, which all contain multivesicular MIICs, have indicated the presence of exosomes at their surface. It can be speculated that in vivo, in the circulation, exosomes may function as transport vehicles for MHC class II-peptide complexes responsible for maintenance of long-term T cell memory or T cell tolerance. Further investigations are required to explore the usefulness of exosomes, in particular as biological vehicles, in immunotherapy.
